Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_assertion type Assertion NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_head.
- NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_assertion description "[Expression levels of AR and CRISP3 were not affected by short-term ADT but were high in castration-resistant prostate cancer (CRPC) and metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_provenance.
- NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_assertion evidence source_evidence_literature NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_provenance.
- NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_assertion SIO_000772 20680031 NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_provenance.
- NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_assertion wasDerivedFrom befree-20140225 NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_provenance.
- NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_assertion wasGeneratedBy ECO_0000203 NP256975.RAWNDO_RmE1L8xQp0atBgkDGMvi2HLgHrhooe4EhofnKQ130_provenance.